Infusion Pumps Market Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

 

Infusion Pumps Market

Drug delivery through ambulatory infusion pumps is crucial in a variety of clinical situations. They are essential in providing patients with chemotherapy, TPN infusion, painkillers, and other infusions in both inpatient and outpatient settings. In order to lower the high cost of medical care, the trend in developed markets is moving away from hospital-based care and toward outpatient care. Ambulatory pumps are likely to experience high demand as demand for outpatient and home care rises.

Every year, the number of surgical operations rises around the world. In 2015–2016, there were 3,281 surgical procedures and 4,154 chemotherapy procedures performed for brain and other CNS cancers, according to the Australian Institute of Health and Welfare. More surgical procedures were performed on men than on women (61% vs. 39%). By 2030, 143 million additional surgical procedures will be required annually to save lives and prevent disability, according to the Lancet Commission on Global Surgery. Medical and technological developments, such as advancements in anesthesia, analgesics for pain relief, and the growth of minimally invasive and noninvasive procedures, are factors that have contributed to this increase. Thus, the global infusion pumps market has benefited from the increase in surgical procedures.

In 2017, the chemo segment held the largest market share for infusion pumps worldwide. The rising incidence of cancer, the expansion of ambulatory infusion pumps for chemotherapy, and the entry of technologically advanced products into this market segment are all factors that contribute to the large share of this market segment.